Literature DB >> 12791650

The homeoprotein Hex is required for hemangioblast differentiation.

Ying Guo1, Rebecca Chan, Heather Ramsey, Weiming Li, Xiaodong Xie, William C Shelley, Juan Pedro Martinez-Barbera, Bernardo Bort, Kenneth Zaret, Mervin Yoder, Robert Hromas.   

Abstract

The first hematopoietic and endothelial progenitors are derived from a common embryonic precursor termed the hemangioblast. The genetic cascades that regulate the differentiation of the hemangioblast to hematopoietic and endothelial cells are largely unknown. In general, much of embryonic development is coordinately regulated by temporal and spatial expression of transcription factors, such as the Homeobox (Hox) gene family. We and others isolated a divergent homeobox gene termed Hex (or Prh) that is preferentially expressed in hematopoietic and endothelial cells. Using in vitro Hex-/- embryonic stem (ES) cell differentiation, in vivo yolk sac hematopoietic progenitor assays, and chimeric mouse analysis, we found that Hex is required for differentiation of the hemangioblast to definitive embryonic hematopoietic progenitors and to a lesser extent endothelial cells. Therefore, Hex is a novel regulator of hemangioblast differentiation to hematopoietic and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791650     DOI: 10.1182/blood-2003-02-0634

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.

Authors:  Peter Noy; Hannah Williams; Anyaporn Sawasdichai; Kevin Gaston; Padma-Sheela Jayaraman
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 2.  Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.

Authors:  Gregor Prindull
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Study of intermolecular contacts in the proline-rich homeodomain (PRH)-DNA complex using molecular dynamics simulations.

Authors:  Seifollah Jalili; Leila Karami
Journal:  Eur Biophys J       Date:  2012-02-04       Impact factor: 1.733

4.  The homeobox gene Hhex regulates the earliest stages of definitive hematopoiesis.

Authors:  Helicia Paz; Maureen R Lynch; Clifford W Bogue; Judith C Gasson
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

Review 5.  Molecular and developmental biology of the hemangioblast.

Authors:  Jing-Wei Xiong
Journal:  Dev Dyn       Date:  2008-05       Impact factor: 3.780

Review 6.  Blood cell generation from the hemangioblast.

Authors:  Christophe Lancrin; Patrycja Sroczynska; Alicia G Serrano; Arnaud Gandillet; Cristina Ferreras; Valerie Kouskoff; Georges Lacaud
Journal:  J Mol Med (Berl)       Date:  2009-10-25       Impact factor: 4.599

7.  Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.

Authors:  Orapan Sripichai; Christine M Kiefer; Natarajan V Bhanu; Toshihiko Tanno; Seung-Jae Noh; Sung-Ho Goh; J Eric Russell; Cheryl L Rognerud; Ching-Nan Ou; Patricia A Oneal; Emily R Meier; Nicole M Gantt; Colleen Byrnes; Y Terry Lee; Ann Dean; Jeffery L Miller
Journal:  Blood       Date:  2009-07-13       Impact factor: 22.113

8.  Study of base pair mutations in proline-rich homeodomain (PRH)-DNA complexes using molecular dynamics.

Authors:  Seifollah Jalili; Leila Karami; Jeremy Schofield
Journal:  Eur Biophys J       Date:  2013-02-06       Impact factor: 1.733

9.  Gene expression programs of mouse endothelial cells in kidney development and disease.

Authors:  Eric W Brunskill; S Steven Potter
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

10.  The PRH/Hex repressor protein causes nuclear retention of Groucho/TLE co-repressors.

Authors:  Cecile Desjobert; Peter Noy; Tracey Swingler; Hannah Williams; Kevin Gaston; Padma-Sheela Jayaraman
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.